Table 1 Sociodemographic, medical characteristics on study participants
TOTAL | |||
|---|---|---|---|
Number | Percent | 95%CI | |
Medical center | |||
University Hospital “Marques de Valdecilla”, Cantabria. | 16 | 6.02 | 3.14–8.89 |
“Fundación Alcorcón” Hospital, Madrid. | 35 | 13.16 | 9.08–17.24 |
University Hospital of Getafe, Madrid. | 17 | 6.39 | 3.44–9.34 |
University Hospital of Fuenlabrada, Madrid. | 52 | 19.55 | 14.76–24.34 |
Catalan Institute of Oncology, University Hospital of Bellvitge, Barcelona. | 35 | 13.16 | 9.08–17..24 |
Catalan Institute of Oncology, University Hospital “Germans Trias i Pujol”, Barcelona. | 45 | 16.92 | 12.39–21.44 |
Hospital “Sierrallana”, Cantabria. | 4 | 1.50 | 0.03–2.97 |
Hospital of Navarra, Navarra. | 47 | 17.67 | 13.06–22.27 |
Hospital of Salamanca, Salamanca. | 5 | 1.88 | 0.24–3.52 |
University Hospital “Puerta de Hierro-Majadahonda”, Madrid. | 10 | 3.76 | 1.46–6.06 |
AGE (years) Mean [SD] | 52.56 | [11.33] | |
Gender | |||
Female | 203 | 76.32 | 71.18–81.45 |
Male | 63 | 23.68 | 18.55–28.82 |
Marital status | |||
Married | 178 | 66.92 | 61.24–72.6 |
Single | 39 | 14.66 | 10.39–18.93 |
Divorced | 11 | 4.14 | 1.73–6.54 |
Widowed | 10 | 3.76 | 1.46–6.06 |
Separated | 11 | 4.14 | 1.73–6.54 |
Domestic partnership | 17 | 6.39 | 3.44–9.34 |
Educational level | |||
Elementary | 131 | 49.25 | 43.21–55.28 |
Secondary | 87 | 32.71 | 27.04–38.37 |
University | 48 | 18.05 | 13.4–22.69 |
Cancer diagnosis | |||
Lung | 31 | 11.65 | 7.78–15.52 |
Digestive | 36 | 13.53 | 9.4–17.66 |
Head and neck | 5 | 1.88 | 0.24–3.52 |
Gynecological | 139 | 52.26 | 46.23–58.29 |
Urinary | 7 | 2.63 | 0,7–4.56 |
Hematological malignancies | 41 | 15.41 | 11.05–19.77 |
Others | 7 | 2.63 | 0.7–4.56 |
Cancer therapy | |||
Chemotherapy | 256 | 96.24 | 93.94–98.54 |
Radiotherapy | 121 | 45.49 | 39.48–51.5 |
Hormone therapy | 52 | 19.55 | 14.76–24.34 |
Biological therapy | 50 | 18.80 | 14.08–23.51 |
Surgery to remove cancer | 147 | 55.26 | 49.26–61.27 |
Side effects of cancer treatment | |||
No | 35 | 13.16 | 9.08–17.24 |
Yes | 231 | 86.84 | 82.76–90.92 |
Cancer pain | |||
No | 142 | 53.38 | 47.36–59.41 |
Yes | 124 | 46.62 | 40.59–52.64 |
Use of analgesics | |||
No | – | – | |
Yes | 124 | 100 | – |
Use of anxiolytics | |||
No | 182 | 68.42 | 62.81–74.03 |
Yes | 84 | 31.58 | 25.97–37.19 |
Use of antidepressants | |||
No | 234 | 87.97 | 84.04–91.9 |
Yes | 32 | 12.03 | 8.1–15.96 |
Use of hypnotics | |||
No | 208 | 78.20 | 73.21–83.18 |
Yes | 58 | 21.80 | 16.82–26.79 |
Symptoms of inclusion in the study | |||
Anxiety | 261 | 98.12 | 96.48–99.76 |
Insomnia | 37 | 13.91 | 9.73–18.09 |
Sadness | 15 | 5.64 | 2.85–8.42 |
Muscle tension | 3 | 1.13 | 0–2.4 |